Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Nebulized furosemide beneficial in patients with acute asthma of short-term duration

May 4, 1998

AxyS Pharmaceuticals' APC-366 shows good antiasthmatic activity in phase IIa trial

May 1, 1998

New PDE IV inhibitors for asthma reported by Celltech

April 30, 1998

Astra obtains rights from Takeda to develop TxA2 antagonist

April 30, 1998

U.K. market introduction for long-acting, nonsedating antihistamine

April 29, 1998

Sepracor completes norastemizole trial; additional studies planned

April 29, 1998

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

April 28, 1998

Glaxo Wellcome seeks approval for combination asthma product

April 28, 1998

Bronchodilating and antiinflammatory agents claimed by Nikken

April 27, 1998

Montelukast shows promise in the treatment of pediatric asthma patients

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...